The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of anamorelin in patients with non–small cell lung cancer and cancer cachexia undergoing chemoimmunotherapy: A real-world prospective cohort study (SPIRAL-ANA).
 
Kenji Morimoto
No Relationships to Disclose
 
Junji Uchino
No Relationships to Disclose
 
Makoto Hibino
No Relationships to Disclose
 
Yuki Takeyasu
No Relationships to Disclose
 
Ken Yamamoto
No Relationships to Disclose
 
Yoshie Morimoto
No Relationships to Disclose
 
Yusuke Chihara
No Relationships to Disclose
 
Takayuki Nakano
No Relationships to Disclose
 
Hiroyasu Kaneda
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; MSD; Ono Pharmaceutical
 
Shunya Tanaka
No Relationships to Disclose
 
Shinsuke Ogusu
No Relationships to Disclose
 
Yasuhiro Goto
No Relationships to Disclose
 
Takayuki Shimose
No Relationships to Disclose
 
Koichi Takayama
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai/Roche; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Ono Pharmaceutical
Research Funding - Boehringer Ingelheim; Chugai/Roche; Ono Pharmaceutical; Taiho Pharmaceutical